Skip to main content
Log in

Emergent Challenges in Determining Costs for Economic Evaluations

  • Practical Application
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

This paper describes methods of determining costs for economic evaluations of healthcare and considers how cost determination is being affected by recent developments in healthcare. The literature was reviewed to identify the strengths and weaknesses of the four principal methods of cost determination: micro-costing, activity-based costing, charge-based costing, and gross costing. A scoping review was conducted to identify key trends in healthcare delivery and to identify costing issues associated with these changes. Existing guidelines provide information on how to implement various costing methods. Bottom-up costing is needed when accuracy is paramount, but top-down approaches are often the only feasible approach. We describe six healthcare trends that have important implications for costing methodology: (1) reform in payment mechanisms; (2) care delivery in less restrictive settings; (3) the growth of telehealth interventions; (4) the proliferation of new technology; (5) patient privacy concerns; and (6) growing efforts to implement guidelines. Some costs are difficult to measure and have been overlooked. These include physician services for inpatients, facility costs for outpatient services, the cost of developing treatment innovations, patient and caregiver costs, and the indirect costs of organizational interventions. Standardized methods are needed to determine social welfare and productivity costs. In the future, cost determination will be facilitated by technological advances but hindered by the shift to capitated payment, to the provision of care in less restrictive settings, and by heightened concern for medical record privacy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.

    Google Scholar 

  2. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.

    Google Scholar 

  3. Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.

    Article  PubMed  Google Scholar 

  4. Adam T, Koopmanschap MA, Evans DB. Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care. 2003;19(2):407–20.

    Article  PubMed  Google Scholar 

  5. Smith MW, Barnett PG. Direct measurement of health care costs. Med Care Res Rev. 2003;60(3 Suppl):74S–91S.

    Article  PubMed  Google Scholar 

  6. Findorff MJ, Wyman JF, Croghan CF, Nyman JA. Use of time studies for determining intervention costs. Nurs Res. 2005;54(4):280–4 (pii:00006199-200507000-00011).

    Article  PubMed  Google Scholar 

  7. Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999;3(6):1–76.

    CAS  PubMed  Google Scholar 

  8. Frick KD. Microcosting quantity data collection methods. Med Care. 2009;47(7 Suppl 1):S76–81. doi:10.1097/MLR.0b013e31819bc064.

  9. Xu X, Grossetta Nardini HK, Ruger JP. Micro-costing studies in the health and medical literature: protocol for a systematic review. Syst Rev. 2014;3:47. doi:10.1186/2046-4053-3-47.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Azoulay A, Doris NM, Filion KB, Caron J, Pilote L, Eisenberg MJ. The use of the transition cost accounting system in health services research. Cost Eff Resour Alloc. 2007;5:11. doi:10.1186/1478-7547-5-11.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ross TK. Analyzing health care operations using ABC. J Health Care Finance. 2004;30(3):1–20.

    PubMed  Google Scholar 

  12. Udpa S. Activity-based costing for hospitals. Health Care Manag Rev. 1996;21(3):83–96.

    Article  CAS  Google Scholar 

  13. Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82(11):131–8, 50.

  14. Udpa S. Activity cost analysis: a tool to cost medical services and improve quality of care. Manag Care Q. 2001;9(3):34–41.

    CAS  PubMed  Google Scholar 

  15. Young DW. The folly of using RCCs and RVUs for intermediate product costing. Healthc Financ Manag. 2007;61(4):100–6, 8.

  16. Kaplan RS, Witkowski M, Abbott M, Guzman AB, Higgins LD, Meara JG, et al. Using time-driven activity-based costing to identify value improvement opportunities in healthcare. J Healthc Manag. 2014;59(6):399–412.

    PubMed  Google Scholar 

  17. Hunkeler EM, Hung YY, Rice DP, Weisner C, Hu T. Alcohol consumption patterns and health care costs in an HMO. Drug Alcohol Depend. 2001;64(2):181–90 (pii:S0376871601001193).

    Article  CAS  PubMed  Google Scholar 

  18. Parthasarathy S, Mertens J, Moore C, Weisner C. Utilization and cost impact of integrating substance abuse treatment and primary care. Med Care. 2003;41(3):357–67. doi:10.1097/01.MLR.0000053018.20700.56.

    PubMed  Google Scholar 

  19. Barnett PG, Rodgers JH. Use of the Decision Support System for VA cost-effectiveness research. Med Care. 1999;37(4 Suppl Va):AS63–70.

  20. Hill NT, Johns EL. Adoption of costing systems by U.S. hospitals. Hosp Health Serv Adm. 1994;39(4):521–37.

  21. Gehlert E, Jacobs JC, Barnett PG. Technical Report 32: costing methods used in VA research, 1980–2012. Menlo Park: VA Palo Alto, Health Economics Resource Center; 2016.

    Google Scholar 

  22. Taira DA, Seto TB, Siegrist R, Cosgrove R, Berezin R, Cohen DJ. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J. 2003;145(3):452–8.

    Article  PubMed  Google Scholar 

  23. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96(1):102–9.

    Article  CAS  PubMed  Google Scholar 

  24. Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009; 47(7 Suppl 1):S51–55.

  25. Centers for Medicare and Medicaid Services. Historical impact files for FY 1994 through present. Baltimore: CMS; 2012. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Historical-Impact-Files-for-FY-1994-through-Present.html. Accessed 21 May 2016.

  26. Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476–81.

    PubMed  Google Scholar 

  27. Phibbs CS, Bhandari A, Yu W, Barnett PG. Estimating the costs of VA ambulatory care. Med Care Res Rev. 2003;60(3 Suppl):54S–73S.

    Article  PubMed  Google Scholar 

  28. Peterson C, Xu L, Florence C, Grosse SD, Annest JL. Professional fee ratios for US hospital discharge data. Med Care. 2015;53(10):840–9. doi:10.1097/MLR.0000000000000410.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Bhandari A, Wagner T. Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev. 2006;63(2):217–35. doi:10.1177/1077558705285298.

    Article  PubMed  Google Scholar 

  30. Barnett PG. Research without billing data. Econometric estimation of patient-specific costs. Med Care. 1997;35(6):553–63.

    Article  CAS  PubMed  Google Scholar 

  31. Tan SS, Rutten FF, van Ineveld BM, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ. 2009;10(1):39–45. doi:10.1007/s10198-008-0101-x.

    Article  CAS  PubMed  Google Scholar 

  32. Chapko MK, Liu CF, Perkins M, Li YF, Fortney JC, Maciejewski ML. Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ. 2009;18(10):1188–201. doi:10.1002/hec.1422.

    Article  PubMed  Google Scholar 

  33. Hardy KM, Kwong J, Pitzul KB, Vergis AS, Jackson TD, Urbach DR, et al. A cost comparison of laparoscopic and open colon surgery in a publicly funded academic institution. Surg Endosc. 2014;28(4):1213–22. doi:10.1007/s00464-013-3311-y.

    Article  PubMed  Google Scholar 

  34. Cooper R, Kramer TR. Revenue-based cost assignment: a potent but hidden threat to the survival of the multispecialty medical practice. Acad Med. 2010;85(3):538–47. doi:10.1097/ACM.0b013e3181cd4cf7.

    Article  PubMed  Google Scholar 

  35. Olsson TM. Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare. Eur J Health Econ. 2011;12(5):9.

    Article  Google Scholar 

  36. Mogyorosy Z, Smith P. The main methodological issues in costing health care services: a literature review. York: University of York, Center for Health Economics; 2005.

    Google Scholar 

  37. Tarricone R. Cost-of-illness analysis. What room in health economics? Health Policy. 2006;77(1):51–63. doi:10.1016/j.healthpol.2005.07.016.

    Article  PubMed  Google Scholar 

  38. Rice DP. Estimating the cost of illness. Am J Public Health Nations Health. 1967;57(3):424–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Institute ECRI. Agency for Healthcare Research and Quality Healthcare Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Rockville: AHRQ; 2015.

    Google Scholar 

  40. Centers for Medicare & Medicaid Services. Better care. Smarter spending. Healthier people: paying providers for value, not volume. Fact Sheets. Baltimore: CMS; 2015. https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-01-26-3.html. Accessed 12 Apr 2015.

  41. Struijs JN, Mohnen SM, Molema CCM, de Jong-VanTil JT, Baan CA. Effects of bundled payment on curative health care costs in the Netherlands: an analysis for diabetes care and vascular risk management based on nationwide claim data, 2007–2010. Bilthoven: National Institute for Public Health and the Environment; 2012.

    Google Scholar 

  42. Lix LM, Yao X, Kephart G, Quan H, Smith M, Kuwornu JP, et al. A prediction model to estimate completeness of electronic physician claims databases. BMJ Open. 2015;5(e006858):8. doi:10.1136/bmjopen-2014-006858.

    Google Scholar 

  43. Alshammari AM, Hux JE. The impact of non-fee-for-service reimbursement on chronic disease surveillance using administrative data. Can J Public Health. 2009;100(6):3.

    Google Scholar 

  44. Akhavan S, Ward L, Bozic KJ. Time-driven activity-based costing more accurately reflects costs in arthroplasty surgery. Clin Orthop Relat Res. 2016;474(1):8–15. doi:10.1007/s11999-015-4214-0.

    Article  PubMed  Google Scholar 

  45. Hilsenrath P, Eakin C, Fischer K. Price-transparency and cost accounting: challenges for health care organizations in the consumer-driven era. Inquiry. 2015;52. doi:10.1177/0046958015574981.

  46. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011;(169):1–38.

  47. Eiken S, Sredl K, Burwell B, Saucier P. Medicaid expenditures for long-term services and supports (LTSS) in FY 2013: home and community-based services were a majority of LTSS spending. Washington, DC: Medicaid.gov; 2015.

    Google Scholar 

  48. Rawson JV, Kassing P. HOPPS: evolution of a CMS process. J Am Coll Radiol. 2007;4(2):102–5. doi:10.1016/j.jacr.2006.09.002.

    Article  PubMed  Google Scholar 

  49. He D, Mellor JM. Medicare payment and hospital provision of outpatient care to the uninsured. Health Serv Res. 2016;51(4):1388–406. doi:10.1111/1475-6773.12433.

    Article  PubMed  Google Scholar 

  50. Centers for Medicare & Medicaid Services. Hospital Outpatient PPS. Baltimore, MD: CMS; 2016. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS/. Accessed 15 Aug 2016.

  51. He D, Mellor JM. Hospital volume responses to Medicare’s outpatient prospective payment system: evidence from Florida. J Health Econ. 2012;31(5):730–43. doi:10.1016/j.jhealeco.2012.06.001.

    Article  PubMed  Google Scholar 

  52. McCaffrey N, Cassel JB, Coast J. Bringing the economic cost of informal caregiving into focus. Palliat Med. 2015;29(10):866–7. doi:10.1177/0269216315612653.

    Article  PubMed  Google Scholar 

  53. Tan SS, Bouwmans CA, Rutten FF, Hakkaart-van Roijen L. Update of the Dutch manual for costing in economic evaluations. Int J Technol Assess Health Care. 2012;28(2):152–8. doi:10.1017/S0266462312000062.

    Article  PubMed  Google Scholar 

  54. Goodrich K, Kaambwa B, Al-Janabi H. The inclusion of informal care in applied economic evaluation: a review. Value Health. 2012;15(6):975–81. doi:10.1016/j.jval.2012.05.009.

    Article  PubMed  Google Scholar 

  55. Zhang W, Bansback N, Anis AH. Measuring and valuing productivity loss due to poor health: a critical review. Soc Sci Med. 2011;72(2):185–92. doi:10.1016/j.socscimed.2010.10.026.

    Article  PubMed  Google Scholar 

  56. Koopmanschap MA, van Exel JN, van den Berg B, Brouwer WB. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26(4):269–80.

    Article  PubMed  Google Scholar 

  57. Russell LB. Completing costs: patients’ time. Med Care. 2009;47(7 Suppl 1):S89–93. doi:10.1097/MLR.0b013e31819bc077.

    Article  PubMed  Google Scholar 

  58. Bergmo TS. How to measure costs and benefits of eHealth interventions: an overview of methods and frameworks. J Med Internet Res. 2015;17(11):e254. doi:10.2196/jmir.4521.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Mistry H, Garnvwa H, Oppong R. Critical appraisal of published systematic reviews assessing the cost-effectiveness of telemedicine studies. Telemed J E Health. 2014;20(7):609–18. doi:10.1089/tmj.2013.0259.

    Article  PubMed  Google Scholar 

  60. Wade VA, Karnon J, Elshaug AG, Hiller JE. A systematic review of economic analyses of telehealth services using real time video communication. BMC Health Serv Res. 2010;10:233. doi:10.1186/1472-6963-10-233.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Bergmo TS. Can economic evaluation in telemedicine be trusted? A systematic review of the literature. Cost Eff Resour Alloc. 2009;7:18. doi:10.1186/1478-7547-7-18.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Reardon T. Research findings and strategies for assessing telemedicine costs. Telemed J E Health. 2005;11(3):348–69. doi:10.1089/tmj.2005.11.348.

    Article  PubMed  Google Scholar 

  63. Baker TB, Gustafson DH, Shah D. How can research keep up with eHealth? Ten strategies for increasing the timeliness and usefulness of eHealth research. J Med Internet Res. 2014;16(2):e36. doi:10.2196/jmir.2925.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Hoyle M, Anderson R. Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts. Med Decis Mak. 2010;30(4):426–37. doi:10.1177/0272989X09353946.

    Article  Google Scholar 

  65. Hoyle M. Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis. Pharmacoeconomics. 2011;29(1):1–15. doi:10.2165/11584230-000000000-00000.

    Article  PubMed  Google Scholar 

  66. Kulynych J, Korn D. The effect of the new federal medical-privacy rule on research. N Engl J Med. 2002;346(3):201–4. doi:10.1056/NEJM200201173460312346/3/201.

    Article  PubMed  Google Scholar 

  67. Gunn PP, Fremont AM, Bottrell M, Shugarman LR, Galegher J, Bikson T. The health insurance portability and accountability act privacy rule: a practical guide for researchers. Med Care. 2004;42(4):321–7 (pii:00005650-200404000-00004).

    Article  PubMed  Google Scholar 

  68. Shen JJ, Samson LF, Washington EL, Johnson P, Edwards C, Malone A. Barriers of HIPAA regulation to implementation of health services research. J Med Syst. 2006;30(1):65–9.

    Article  PubMed  Google Scholar 

  69. Hussey PS, Anderson GF, Osborn R, Feek C, McLaughlin V, Millar J, et al. How does the quality of care compare in five countries? Health Aff (Millwood). 2004;23(3):89–99.

    Article  PubMed  Google Scholar 

  70. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45. doi:10.1056/NEJMsa022615.

    Article  PubMed  Google Scholar 

  71. Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–20. doi:10.1258/jrsm.2011.110180.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Principal Investigators CTSA, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, et al. Preparedness of the CTSA’s structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci. 2012;5(2):121–9. doi:10.1111/j.1752-8062.2012.00401.x.

    Article  Google Scholar 

  73. Demakis JG, McQueen L, Kizer KW, Feussner JR. Quality Enhancement Research Initiative (QUERI): a collaboration between research and clinical practice. Med Care. 2000;38(6 Suppl 1):I17–25.

    CAS  PubMed  Google Scholar 

  74. Hoomans T, Evers SM, Ament AJ, Hubben MW, van der Weijden T, Grimshaw JM, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health. 2007;10(4):305–16. doi:10.1111/j.1524-4733.2007.00175.x.

    Article  PubMed  Google Scholar 

  75. Vale L, Thomas R, MacLennan G, Grimshaw J. Systematic review of economic evaluations and cost analyses of guideline implementation strategies. Eur J Health Econ. 2007;8(2):111–21. doi:10.1007/s10198-007-0043-8.

    Article  PubMed  Google Scholar 

  76. Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care. 2003;12(5):366–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Fortney JC, Pyne JM, Burgess JF Jr. Population-level cost-effectiveness of implementing evidence-based practices into routine care. Health Serv Res. 2014;49(6):1832–51. doi:10.1111/1475-6773.12247.

    PubMed  PubMed Central  Google Scholar 

  78. Liu CF, Rubenstein LV, Kirchner JE, Fortney JC, Perkins MW, Ober SK, et al. Organizational cost of quality improvement for depression care. Health Serv Res. 2009;44(1):225–44. doi:10.1111/j.1475-6773.2008.00911.x.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Sathe NA, Nocon RS, Hughes B, Peek ME, Chin MH, Huang ES. The costs of participating in a diabetes quality improvement collaborative: variation among five clinics. Jt Comm J Qual Patient Saf. 2016;42(1):18–25.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals? JAMA. 2001;286(23):2988–92 (pii:jsc10303).

    Article  CAS  PubMed  Google Scholar 

  81. Centers for Medicare & Medicaid Services. National Health Expenditures 2014 Highlights. 2015. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/highlights.pdf. Accessed 19 May 2016.

Download references

Author contributions

JJ and PB both contributed to the conceptualization, literature search, synthesis and drafting of the paper. Both authors act as the guarantor for this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Josephine C. Jacobs.

Ethics declarations

JJ and PB declare have no conflicts of interest. This research was supported by the US Department of Veterans Affairs Health Services Research and Development Service (ECN-99-017-16S2).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jacobs, J.C., Barnett, P.G. Emergent Challenges in Determining Costs for Economic Evaluations. PharmacoEconomics 35, 129–139 (2017). https://doi.org/10.1007/s40273-016-0465-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-016-0465-1

Keywords

Navigation